[Polyanionic inhibitors of HIV adsorption]

Area of Science:

• Virology
• Drug Discovery
• Immunology

Background:

• Human Immunodeficiency Virus (HIV) entry into host cells is a critical step in infection.
• Current HIV treatments focus on various stages of the viral lifecycle.
• Understanding viral entry mechanisms is key to developing novel therapeutics.

Purpose of the Study:

• To review the different classes of HIV entry inhibitors.
• To categorize these inhibitors based on the specific viral adsorption and fusion processes they target.
• To highlight the potential of these inhibitors as a new generation of antiviral drugs for HIV treatment.

Main Methods:

• Literature review of scientific publications on HIV entry inhibitors.
• Classification of inhibitors based on their mechanism of action at different stages of viral entry.
• Analysis of the targeted molecular interactions: gp120-CD4 binding, gp120-chemokine receptor interaction, and gp41-mediated fusion.

Main Results:

• Identified distinct classes of HIV entry inhibitors.
• Detailed the specific viral processes inhibited: initial attachment, coreceptor engagement, and membrane fusion.
• Highlighted the role of viral glycoprotein 120 (gp120) and glycoprotein 41 (gp41) in viral entry.

Conclusions:

• Viral adsorption inhibitors represent a promising new generation of antiviral drugs.
• Targeting specific steps in HIV entry, such as viral adsorption and fusion, offers effective therapeutic strategies.
• Further development of these inhibitors could lead to improved treatments for HIV infection.